Clinical Trial

Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 29, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To measure the efficacy of postbiotic supplements in mitigating the gut dysbiosis induced by colon cancer surgery. Efficacy in mitigating dysbiosis will be measured by the change in fecal Shannon Diversity Index (SDI) within patients from the baseline sample to various postoperative timepoints. Mean change in SDI from baseline will be compared between groups at 2 weeks postoperative
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-02.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-19
Trial Details
NCT Number NCT07050485
Lead Sponsor University of South Florida
Conditions Colon Cancer, Gastrointestinal Cancer
Enrollment 30 participants
Start Date 2025-07-15
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-29